Annovis Bio
ANVS
ANVS
32 hedge funds and large institutions have $19.6M invested in Annovis Bio in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Morgan Stanley
New York
|
+$2.06M |
2 |
BlackRock
New York
|
+$778K |
3 |
Two Sigma Advisers
New York
|
+$591K |
4 |
Citadel Advisors
Miami,
Florida
|
+$386K |
5 |
BAM
Blueshift Asset Management
Red Bank,
New Jersey
|
+$289K |
Top Sellers
1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$2.11M |
2 |
Voloridge Investment Management
Jupiter,
Florida
|
-$1.5M |
3 |
Two Sigma Investments
New York
|
-$806K |
4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$631K |
5 |
VF
Virtu Financial
New York
|
-$367K |